Stay updated with breaking news from Aptamer Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aptamer Group PLC shares rose on Monday, after it noted progression on its contract with Unilever PLC. Shares in the York, England-based biotechnology firm were up 10% to 0.80 pence each in London on...
Aptamer Group PLC on Tuesday said its new Optimer+ platform delivers improved results compared to standard binders. The York, England-based biotechnology firm said its updated Optimer+ platform can...
Firms seek to develop animal-free binders for lateral flow test to detect disease early
Aptamer Group PLC on Thursday said it has entered the second phase of developing Optimer binders for the early diagnosis of Alzheimer's disease alongside Neuro-Bio Ltd. Shares in Aptamer were up 14%...
Aptamer Group plc, the developer of novel Optimer binders to enable innovation in the life sciences industry, announces the second phase of its on-going partnership with Neuro-Bio, an Oxfordshire-based biotechnology company with a therapeutic focus on neurodegenerative disease, to develop Optimer binders for a lateral flow test for the early diagnosis of Alzheimer’s disease